-
1
-
-
0032694077
-
Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream
-
Beutner KR, Geisse JK, Helman D, Fox TL, Ginkel A, Owens ML, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol 1999;41:1002-7.
-
(1999)
J Am Acad Dermatol
, vol.41
, pp. 1002-1007
-
-
Beutner, K.R.1
Geisse, J.K.2
Helman, D.3
Fox, T.L.4
Ginkel, A.5
Owens, M.L.6
-
2
-
-
2042534210
-
Safety and efficacy trial evaluating 5% imiquimod cream in the treatment of Bowen's disease with once daily application
-
Poster presented Orlando, FL, Feb 27-May 4
-
Mackenzie-Wood A, de Laudney J, Kossard S, Svans R, Fox T, Owens M. Safety and efficacy trial evaluating 5% imiquimod cream in the treatment of Bowen's disease with once daily application. Poster presented at the 56th Annual Meeting of the American Academy of Dermatology, Orlando, FL, Feb 27-May 4, 1998.
-
(1998)
56th Annual Meeting of the American Academy of Dermatology
-
-
Mackenzie-Wood, A.1
De Laudney, J.2
Kossard, S.3
Svans, R.4
Fox, T.5
Owens, M.6
-
3
-
-
84944282549
-
Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris
-
Vance JC, Bart BJ, Hansen RC, Reichman RC, McEwen C, Hatch KD, et al. Intralesional recombinant alpha-2 interferon for the treatment of patients with condyloma acuminatum or verruca plantaris. Arch Dermatol 1986;122:272-7.
-
(1986)
Arch Dermatol
, vol.122
, pp. 272-277
-
-
Vance, J.C.1
Bart, B.J.2
Hansen, R.C.3
Reichman, R.C.4
McEwen, C.5
Hatch, K.D.6
-
4
-
-
0023006899
-
Interferon therapy for condylomata acuminata
-
Eron LJ, Judson F, Tucker S, Prawer S, Mills J, Murphy K, et al. Interferon therapy for condylomata acuminata. N Engl J Med 1986;315:1059-64.
-
(1986)
N Engl J Med
, vol.315
, pp. 1059-1064
-
-
Eron, L.J.1
Judson, F.2
Tucker, S.3
Prawer, S.4
Mills, J.5
Murphy, K.6
-
6
-
-
0031976655
-
Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts
-
Beutner KR, Tyring SK, Trofatter KF Jr, Douglas JM Jr, Spruance S, Owens ML. Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts. Antimicrob Agents Chemother 1998;42:789-94.
-
(1998)
Antimicrob Agents Chemother
, vol.42
, pp. 789-794
-
-
Beutner, K.R.1
Tyring, S.K.2
Trofatter Jr., K.F.3
Douglas Jr., J.M.4
Spruance, S.5
Owens, M.L.6
-
7
-
-
0032694153
-
Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease
-
Buckley R, Smith K. Topical imiquimod therapy for chronic giant molluscum contagiosum in a patient with advanced human immunodeficiency virus 1 disease. Arch Dermatol 1999;135:1167-9.
-
(1999)
Arch Dermatol
, vol.135
, pp. 1167-1169
-
-
Buckley, R.1
Smith, K.2
-
8
-
-
0031900829
-
Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463
-
Imbertson LM, Beaurline JM, Couture AM, Gibson SJ, Smith RM, Miller RL, et al. Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463. J Invest Dermatol 1998;110:734-9.
-
(1998)
J Invest Dermatol
, vol.110
, pp. 734-739
-
-
Imbertson, L.M.1
Beaurline, J.M.2
Couture, A.M.3
Gibson, S.J.4
Smith, R.M.5
Miller, R.L.6
-
9
-
-
0031853904
-
A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod
-
Tyring SK, Arany I, Stanley MA, Tomai MA, Miller RL, Smith MH, et al. A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod. J Infect Dis 1998;178:551-5.
-
(1998)
J Infect Dis
, vol.178
, pp. 551-555
-
-
Tyring, S.K.1
Arany, I.2
Stanley, M.A.3
Tomai, M.A.4
Miller, R.L.5
Smith, M.H.6
-
10
-
-
0343485063
-
The imidazoquinolines, imiquimod and R-848, induce functional but not phenotypic maturation of human epidermal Langerhans' cells
-
Burns RP Jr, Ferbel B, Tomai M, Miller R, Gaspari AA. The imidazoquinolines, imiquimod and R-848, induce functional but not phenotypic maturation of human epidermal Langerhans' cells. Clin Immunol 2000;94:13-23.
-
(2000)
Clin Immunol
, vol.94
, pp. 13-23
-
-
Burns Jr., R.P.1
Ferbel, B.2
Tomai, M.3
Miller, R.4
Gaspari, A.A.5
-
11
-
-
0031886680
-
Self-administered topical 5% imiquimod cream for external anogenital warts
-
Edwards L, Ferenczy A, Eron L, Baker D, Owens ML, Fox TL, et al. Self-administered topical 5% imiquimod cream for external anogenital warts. Arch Dermatol 1998;134:25-30.
-
(1998)
Arch Dermatol
, vol.134
, pp. 25-30
-
-
Edwards, L.1
Ferenczy, A.2
Eron, L.3
Baker, D.4
Owens, M.L.5
Fox, T.L.6
-
12
-
-
0017643410
-
Induction of hair growth in alopecia areata with DNCB
-
Happle R, Echternacht K. Induction of hair growth in alopecia areata with DNCB. Lancet 1977;2:1002-3.
-
(1977)
Lancet
, vol.2
, pp. 1002-1003
-
-
Happle, R.1
Echternacht, K.2
-
13
-
-
0026717120
-
Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine
-
Sidky YA, Bordon EC, Weeks CE, Reiter MJ, Hatcher JF, Bryan GT. Inhibition of murine tumor growth by an interferon-inducing imidazoquinolinamine. Cancer Res 1992;52:3528-33.
-
(1992)
Cancer Res
, vol.52
, pp. 3528-3533
-
-
Sidky, Y.A.1
Bordon, E.C.2
Weeks, C.E.3
Reiter, M.J.4
Hatcher, J.F.5
Bryan, G.T.6
-
14
-
-
0027420347
-
Phase I trial of an oral immunomodulator and interferon inducer in cancer patients
-
Witt PL, Ritch PS, Reding D, McAuliffe TL, Westrick L, Grossberg SE, et al. Phase I trial of an oral immunomodulator and interferon inducer in cancer patients. Cancer Res 1993;53:5176-80.
-
(1993)
Cancer Res
, vol.53
, pp. 5176-5180
-
-
Witt, P.L.1
Ritch, P.S.2
Reding, D.3
McAuliffe, T.L.4
Westrick, L.5
Grossberg, S.E.6
|